Previous 10 | Next 10 |
2024-01-15 12:40:00 ET Summary All decisions around investing, everything we're seeing everyone doing is now colored by the rate situation. Artificial intelligence is a constantly growing and transforming phenomenon. Unlike artificial intelligence, a lot of the most exciting a...
2024-01-14 03:40:00 ET Summary Shanghai Argo Biopharma entered two agreements with Novartis for a total value of $4.2 billion. San Diego’s Ambrx Biopharma will be acquired by Johnson & Johnson for $2 billion. GSK plans to acquire Aiolos Bio, a San Francisco-London s...
2024-01-12 11:27:00 ET Summary Horiba is likely undervalued due to it being under followed, and offers a rare combination of a quality business at an attractive price. The company has high market share in specialized devices in various industries, including automotive, process &am...
2024-01-09 12:36:13 ET More on United States 30-Year Bond Yield: BofA’s FMS: Investor sentiment has picked up with higher growth expectations for 2024 Moody's cuts United States credit outlook to negative, reaffirms ratings For further details see: Ten sur...
2024-01-08 12:53:29 ET Summary Large pharma stocks, including Johnson & Johnson, may be experiencing a shift in favor as investors move away from glamour growth stocks as 2024 gets underway. Johnson & Johnson is a leading global healthcare company with a below-market valua...
2024-01-08 08:31:52 ET Summary The healthcare sector was flat in 2023 year as a result of some unique issues. Drug price regulation will be a serious challenge for the sector this year. Defensive healthcare industry groups should do well during the first half and biotechnology...
2024-01-07 04:45:00 ET Summary Suzhou Ribo Life Science formed a collaboration with Boehringer Ingelheim in a deal that could be worth up to $2 billion. Suzhou MediLink Therapeutics out-licensed global rights for its pre-clinical c-Mesenchymal epithelial transition factor ADC to R...
2024-01-06 08:15:00 ET Summary Global equity markets experienced a surge in 2023 driven by economic growth and investor confidence. US equity returns exceeded expectations despite concerns about higher rates, inflation, and geopolitical tension. In 2024, investors should focus...
2023-12-21 14:50:28 ET More on iShares U.S. Pharmaceuticals ETF IHE: You Better Like Eli Lilly And Johnson & Johnson To Buy This Seeking Alpha’s Quant Rating on iShares U.S. Pharmaceuticals ETF Dividend scorecard for iShares U.S. Pharmaceuticals ETF ...
BlackRock, Inc. (NYSE: BLK) today announced its plans to implement stock splits for the ETFs listed below. These splits will lower the share price and increase the number of outstanding shares. The total value of shares outstanding is not affected by the share split. For the iShares Core S&am...
News, Short Squeeze, Breakout and More Instantly...
iShares U.S. Pharmaceutical Company Name:
IHE Stock Symbol:
NYSE Market:
The first-quarter results of the healthcare sector have been unimpressive, with earnings of 78% of the sector participants that have reported so fa...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 10.4% to $2.84 on volume of 227,035,753 shares PROSHARES TRUST (SQQQ) fell 4.3% to $10.51 on volume of 164,770,388 shares Canoo Inc. (GOEV) rose 14.1% to $0.099 on volume of 146,...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 10.1% to $2.8499 on volume of 186,670,735 shares PROSHARES TRUST (SQQQ) fell 4.5% to $10.49 on volume of 141,347,975 shares Canoo Inc. (GOEV) rose 16.8% to $0.1014 on volume of 1...